CLAIM CARD
Observational data from a cohort study following transcatheter aortic valve implantation (TAVI) provided more mixed evidence. The RASTAVI trial, a prospective randomized open, blinded endpoint (PROBE) design, compared ramipril with standard care in patients without reduced ejection fraction.
Evidence grade: exploratory
Contradiction status: none
Publication: 9ab2e887-2e5b-429a-8d89-fd6d7813a028
Provenance: Derivation Web chain
Citation Support
source_1Lin 2026source_2Din 2026source_3Spiegeleer 2025source_4Shen 2025source_5Bene 2025